Bystritsky A - Search Results

1

Differential efficacy of memantine for obsessive-compulsive disorder vs. generalized anxiety disorder: an open-label trial.

Feusner JD, Kerwin L, Saxena S, Bystritsky A. Feusner JD, et al. Among authors: bystritsky a. Psychopharmacol Bull. 2009;42(1):81-93. Psychopharmacol Bull. 2009. PMID: 19204653 Clinical Trial.

2

An overview of anxiety disorders.

Pasnau RO, Bystritsky A. Pasnau RO, et al. Among authors: bystritsky a. Bull Menninger Clin. 1990 Spring;54(2):157-70. Bull Menninger Clin. 1990. PMID: 2194605 Review.

3

Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine.

Ackerman DL, Greenland S, Bystritsky A, Morgenstern H, Katz RJ. Ackerman DL, et al. Among authors: bystritsky a. J Clin Psychopharmacol. 1994 Aug;14(4):247-54. J Clin Psychopharmacol. 1994. PMID: 7962680 Clinical Trial.

4

Inert placebo versus active medication. Patient blindability in clinical pharmacological trials.

Bystritsky A, Waikar SV. Bystritsky A, et al. J Nerv Ment Dis. 1994 Sep;182(9):485-7. doi: 10.1097/00005053-199409000-00001. J Nerv Ment Dis. 1994. PMID: 8083675 Clinical Trial.

5

Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder.

Saxena S, Wang D, Bystritsky A, Baxter LR Jr. Saxena S, et al. Among authors: bystritsky a. J Clin Psychiatry. 1996 Jul;57(7):303-6. J Clin Psychiatry. 1996. PMID: 8666572 Clinical Trial.

6

A preliminary study of partial hospital management of severe obsessive-compulsive disorder.

Bystritsky A, Munford PR, Rosen RM, Martin KM, Vapnik T, Gorbis EE, Wolson RC. Bystritsky A, et al. Psychiatr Serv. 1996 Feb;47(2):170-4. doi: 10.1176/ps.47.2.170. Psychiatr Serv. 1996. PMID: 8825254

7

Relationship between early side effects and therapeutic effects of clomipramine therapy in obsessive-compulsive disorder.

Ackerman DL, Greenland S, Bystritsky A, Katz RJ. Ackerman DL, et al. Among authors: bystritsky a. J Clin Psychopharmacol. 1996 Aug;16(4):324-8. doi: 10.1097/00004714-199608000-00009. J Clin Psychopharmacol. 1996. PMID: 8835709 Clinical Trial.

8

Use of receiver-operator characteristic (ROC) curve analysis to evaluate predictors of response to clomipramine therapy.

Ackerman DL, Greenland S, Bystritsky A. Ackerman DL, et al. Among authors: bystritsky a. Psychopharmacol Bull. 1996;32(1):157-65. Psychopharmacol Bull. 1996. PMID: 8927667 Clinical Trial.

9

Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.

Small GW, Bystritsky A. Small GW, et al. Among authors: bystritsky a. J Clin Psychiatry. 1997;58 Suppl 11:24-9. J Clin Psychiatry. 1997. PMID: 9363045 Clinical Trial.

10

Characteristics of fluoxetine versus placebo responders in a randomized trial of geriatric depression.

Ackerman DL, Greenland S, Bystritsky A, Small GW. Ackerman DL, et al. Among authors: bystritsky a. Psychopharmacol Bull. 1997;33(4):707-14. Psychopharmacol Bull. 1997. PMID: 9493483 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

163 results

Search Page

Filters